Ellen van der Plas
Associate Professor
Also affiliated: Leiden University (2008); California Institute of Technology (2011); University of Iowa (2008–2024); Arkansas Children's Hospital (2023–2026); Harvard University (2011); University of Antwerp (2018); University of Toronto (2016); University of Washington (2011); Commissariat à l'Énergie Atomique et aux Énergies Alternatives (2009–2011); University of Arkansas Medical Center (2024); Glasgow Royal Infirmary (2022); Hospital for Sick Children (2013–2017); University of Iowa Hospitals and Clinics (2010–2022); Massachusetts General Hospital (2011); CEA Cadarache (2009–2011); Arkansas Children's Nutrition Center (2025); Queen Elizabeth University Hospital (2020); Instituto de Investigaciones Psicológicas (2008); Flemish Institute for Technological Research (2016–2018); University of Glasgow (2021)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Ellen van der Plas investigates neurological and cognitive outcomes across various patient populations. Her research group's work includes studies on cognitive impairment in survivors of pediatric acute lymphoblastic leukemia treated with chemotherapy, exploring brain imaging correlates of these impairments. She also examines the relationship between neurofilament light-chain protein, brain structure, and chronic kidney disease.
Further research by van der Plas focuses on adult-onset myotonic dystrophy type 1, characterizing its core brain symptoms, including cognitive deficits, apathy, and hypersomnolence. Her work also extends to Huntington's disease, investigating neurofilament light protein as a potential blood biomarker for the pediatric form and analyzing longitudinal clinical and biological characteristics of juvenile-onset Huntington's disease. Additionally, she has studied age-related cognitive changes in carriers of mutant huntingtin.
Van der Plas holds an h-index of 23 with 1,734 total citations across 92 publications. She collaborates with several researchers at the University of Arkansas for Medical Sciences, including Timothy R. Koscik, with whom she shares 13 publications.
Metrics
- h-index: 23
- Publications: 92
- Citations: 1,751
Selected Publications
-
Long-Term Brain White Matter Outcomes Following Neonatal Acute Kidney Injury (2026)
-
Feasibility of Non-Sedated Multispectral Neuroimaging in Newly Diagnosed Children with Leukemia (2026)
-
A supervised STreNgth & Outpatient Exercise Regimen in pediatric patients with Acute Lymphoblastic Leukemia (STRONGER ALL) (2026)
-
Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease (2025)
-
Association Between Sensorineural Hearing Loss and Neurocognitive Performance in Survivors of Childhood Cancer: A Systematic Review and Meta‐Analysis (2025)
-
Central Nervous System Iron Content in Pediatric CKD (2025)
-
Diabetes mellitus and neurocognition: A report from the Childhood Cancer Survivor Study (2025)
-
Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease (2025)
-
An Activation Likelihood Estimation Meta-Analysis of Voxel-Based Morphometry Studies of Chemotherapy-Related Brain Volume Changes in Breast Cancer (2025)
-
A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects (2025)
-
130 A supervised strength and outpatient exercise regimen in pediatric patients with acute lymphoblastic leukemia (STRONGER ALL) (2025)
-
Age-Related Changes in Brain Structure in Pediatric Chronic Kidney Disease (2025)
-
A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects (2024)
-
Characterization of brain development with neuroimaging in a female mouse model of chemotherapy treatment of acute lymphoblastic leukemia (2024)
-
Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study (2024)
Collaboration Network
Top Collaborators
- Neurocognitive deficits may not resolve following pediatric kidney transplantation
- Understanding the impact of pediatric kidney transplantation on cognition: A review of the literature
- Age-Related Changes in Brain Structure in Pediatric Chronic Kidney Disease
- Longitudinal changes in white matter as measured with diffusion tensor imaging in adult-onset myotonic dystrophy type 1
- A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects
- A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects
- Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study
- Characterization of brain development with neuroimaging in a female mouse model of chemotherapy treatment of acute lymphoblastic leukemia
- Diabetes mellitus and neurocognition: A report from the Childhood Cancer Survivor Study
- Neurocognitive deficits may not resolve following pediatric kidney transplantation
- Understanding the impact of pediatric kidney transplantation on cognition: A review of the literature
- Longitudinal changes in white matter as measured with diffusion tensor imaging in adult-onset myotonic dystrophy type 1
- Characterization of brain development with neuroimaging in a female mouse model of chemotherapy treatment of acute lymphoblastic leukemia
- Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study
- Diabetes mellitus and neurocognition: A report from the Childhood Cancer Survivor Study
- Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study
- Diabetes mellitus and neurocognition: A report from the Childhood Cancer Survivor Study
- A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects
- A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects
- A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects
- A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects
- A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects
- A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects
- A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects
- A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects
- A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects
- A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects
- A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects
- A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects
- A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects
- A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects
- A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects
- A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects
Similar Researchers
Based on overlapping research topics